Literature DB >> 23832550

Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis.

Xiao-Dong Xu1, Xu-Jun He, Hou-Quan Tao, Wei Zhang, Yuan-Yu Wang, Zai-Yuan Ye, Zhong-Sheng Zhao.   

Abstract

BACKGROUND AND OBJECTIVES: miR-301a is significantly overexpressed in many cancers. However, its expression and biological role in gastric cancer remain poorly understood. We investigated microRNA-301a (miR-301a) expression in gastric cancer and determined its effects on cancer cell behavior and its clinical significance in the development and progression of gastric cancer.
METHODS: We determined miR-301a expression in gastric tumors and gastric cancer cell lines by reverse transcription-polymerase chain reaction. The effects of miR-301a on cell clone formation, migration, and invasion of HGC-27 and SGC-7901 cells were detected following transfection of an miR-301a inhibitor. miR-301a expression in a 304-tissue gastric cancer microarray was determined by in situ hybridization and its role in progression and prognosis was analyzed.
RESULTS: miR-301a was upregulated in gastric tumor tissues and cell lines. Down-regulation of miR-301a significantly inhibited cell clone formation, migration, and invasion of HGC-27and SGC-7901 cells. Overexpression of miR-301a in primary gastric cancer tissues was associated with tumor size, invasion depth, lymph node metastasis, and TNM stage.
CONCLUSIONS: miR-301a overexpression correlated with TNM stage and prognosis, suggesting that miR-301a is involved in cellular clone formation, migration, and invasion in vitro and may play an important role in the clinical progression and prognosis of gastric cancer.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  gastric cancer; miR-301a; prognosis; progression

Mesh:

Substances:

Year:  2013        PMID: 23832550     DOI: 10.1002/jso.23374

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  19 in total

Review 1.  The clinical value of ncRNAs in gastric cancer: a systematic review and meta-analyses.

Authors:  Xiaoyun Ding; Xiangxiang Wan; Haizhong Jiang; Haojun Song; Ying Fang; Shengcan Chen; Peifei Li; Junming Guo
Journal:  Tumour Biol       Date:  2015-06

2.  Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancer.

Authors:  Hong Yu; Hui Li; Hua Qian; Xia Jiao; Xiaowei Zhu; Xiaoqin Jiang; Guihong Dai; Junxing Huang
Journal:  Med Oncol       Date:  2014-10-14       Impact factor: 3.064

Review 3.  MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.

Authors:  Christiane Matuszcak; Joerg Haier; Richard Hummel; Kirsten Lindner
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 4.  Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.

Authors:  Danilo do Rosário Pinheiro; Wallax Augusto Silva Ferreira; Mariceli Baia Leão Barros; Mariana Diniz Araújo; Symara Rodrigues-Antunes; Bárbara do Nascimento Borges
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.

Authors:  Heng Liu; Gangyue Wang
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

6.  Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals.

Authors:  Hongjun Xie; Lei Li; Guodong Zhu; Qiang Dang; Zhenkun Ma; Dalin He; Luke Chang; Wenbing Song; Hong-Chiang Chang; John J Krolewski; Kent L Nastiuk; Shuyuan Yeh; Chawnshang Chang
Journal:  Oncotarget       Date:  2015-05-20

7.  MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.

Authors:  Xiang Xia; Kundong Zhang; Gang Cen; Tao Jiang; Jun Cao; Kejian Huang; Chen Huang; Qian Zhao; Zhengjun Qiu
Journal:  Oncotarget       Date:  2015-08-28

8.  Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study.

Authors:  Robert K Nam; Yutaka Amemiya; Tania Benatar; Christopher J D Wallis; Jessica Stojcic-Bendavid; Stephanie Bacopulos; Christopher Sherman; Linda Sugar; Magda Naeim; Wenyi Yang; Aiguo Zhang; Laurence H Klotz; Steven A Narod; Arun Seth
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

9.  Glycine confers neuroprotection through microRNA-301a/PTEN signaling.

Authors:  Juan Chen; Yang Zhuang; Zhi-Feng Zhang; Shu Wang; Ping Jin; Chunjiang He; Peng-Chao Hu; Ze-Fen Wang; Zhi-Qiang Li; Guang-Ming Xia; Gang Li; Yuan Wang; Qi Wan
Journal:  Mol Brain       Date:  2016-05-26       Impact factor: 4.041

10.  Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma.

Authors:  H Pandit; W Zhang; Y Li; S Agle; X Li; S P Li; G Cui; Y Li; R C G Martin
Journal:  Cancer Gene Ther       Date:  2015-09-18       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.